Clinical Trials Logo

Clinical Trial Summary

Existing evidence has shown that medical affairs pharmaceutical physicians (MAPPs), are a core function within the pharmaceutical industry. Despite their expertise, there are ongoing concerns about recognition and respect for the MAPP's role within the pharmaceutical industry. Anecdotal evidence further suggests that this lack of recognition and respect for the valuable contribution of this specialised group of medical doctors may impact their quality of life, resulting in stress, anxiety, depression and occupational burnout. Hence, participants are likely to use NHS services as patients, when experiencing the physical, mental, and emotional issues associated with occupational burnout, an internationally recognised condition (ICD-11 code QD85) resulting from chronic occupational stress. This observational study will recruit participants to contribute data to creating a MAPP work-related participant-reported outcome measure on the impact of work-related performance on quality of life (QoL). The created MAPP work-related participant-reported measure will be used longitudinally with study participants to measure their QoL monthly for 12 months. In total, up to 180 Medical Affairs Pharmaceutical Physicians are expected to be recruited to the study. The study will be conducted in two main phases, involving three online surveys.

Clinical Trial Description

Phase One - the development of a MAPP work-related participant-reported quality of life (MAPPWrQoL) measure The study will recruit between nine and 15 participants in this phase. Firstly, a novel method, the Jandhyala Method [16], will be used to elicit medical affairs pharmaceutical physicians' preferences for a QoL tool addressing work-related performance. Below is the outline of activities to be completed during Phase One: 1. Awareness Round survey (first survey, hosted on Survey Monkey) - asking for areas of their life which the participants feel have been impacted by work-related performance, including details and examples of those impacts. 2. The research team will collate and code these responses and generate a list of statements based on the information provided by participants. 3. Consensus Round survey (second survey, hosted on Survey Monkey) - the list of statements will be sent to participants. Participants will be asked to rate their agreement or disagreement with the inclusion of these areas in a MAPP work-related QoL tool. 4. The research team will collate this information, group it into relevant domains and develop a weighting tool. 5. Weighting tool (online Microsoft excel template) - participants will be asked to assign a percentage value (as weights) to the individual items and domains for the finalised MAPP work-related QoL tool using an online excel spreadsheet template. 6. The research team will use this information to develop the finalised MAPP work-related QoL measure to be completed by participants and to develop the system to score this tool. The research team expect the Awareness Round survey (first survey) to be completed within a month. Following this, two weeks will be allocated for the research team to analyse and finalise the survey to be used during the Consensus Round (second survey). The consensus Round survey will be open for two weeks, and participants will be prompted after one week if yet to complete the survey. We will send five reminder emails to the participants. The research team will have two weeks to complete the weighting tool, and participants will be given another two weeks to complete this. The research team will have an additional two weeks to finalise the MAPP work-related QoL at this stage. Thus, it is expected that Phase one activities will take up to 3 months to complete. Phase two - the longitudinal completion of the quality of life tool by Medical Affairs Pharmaceutical Physicians each month for 12 months - observational patient study (MAPPWrQoLReg) Following the MAPP work-related QoL tool development, the research team will recruit additional participants to complete the developed tool monthly for 12 months. The research team will aim to recruit a maximum of 165 study participants for this phase. Participants involved in Phase one will have the option to continue to Phase two. However, participation in Phase two is not a criterion for participation in Phase one. Recruitment will remain open for phase two for a minimum of one year and then reviewed, with another year following this to gain the full 12 months of data from participants. The finalised MAPP work-related QoL measure will be hosted on a secure online system (Survey Monkey), and participants will be allocated an identification (ID) record number. Participants will be asked to complete this measure at monthly intervals for 12 months. Statistical methods for this phase will be finalised when the measure has been completed at the end of phase one by the Biostatistician Team at Medialis Ltd. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05123846
Study type Observational
Source Medialis Ltd.
Contact Omolade Femi-Ajao, PhD
Phone +447502228066
Email [email protected]
Status Recruiting
Start date November 3, 2021
Completion date October 2026

See also
  Status Clinical Trial Phase
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Not yet recruiting NCT04893876 - The OPERa Study: Evaluating QoL After Rectal Cancer Surgery
Recruiting NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Recruiting NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Active, not recruiting NCT03525327 - University of Southern California Choreographic Institute Line Dance Study
Completed NCT03663075 - Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women N/A
Recruiting NCT04874584 - Culturally Tailored Nurse Coaching Study for Cancer Symptom Management N/A
Recruiting NCT04591574 - ABC - A Post Intensive Care Anaemia Management Trial N/A
Completed NCT03503838 - A Pilot Study of Online Yoga for MPN Patients N/A
Recruiting NCT03222648 - Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis N/A
Terminated NCT01228864 - Brody Belt - Alternative Method of Securing a Patient's Urinary Drainage Bag N/A
Recruiting NCT05007041 - Simultaneous RZV and aIIV4 Vaccination Phase 4
Not yet recruiting NCT04497025 - Conventional Vestibular Training Versus Immersive Virtual Reality- Based Vestibular in Multiple Sclerosis N/A
Not yet recruiting NCT04759326 - Neurorehabilitation Through Hippotherapy of a Brain Stroke N/A
Not yet recruiting NCT04386135 - DESVELA. Personal Skills as Determinants of Morbidity, Lifestyles, Quality of Life, Use of Services and Mortality.
Not yet recruiting NCT03150927 - Clinical Study of Novel Probiotic Microbial Composite™ to Treat Undernourished Young Children N/A